These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [The time has come of a therapeutic (re)positioning of the ultra-rare diseases]. Martinat C; Peschanski M Med Sci (Paris); 2018 Dec; 34(12):1019-1021. PubMed ID: 30623755 [No Abstract] [Full Text] [Related]
14. Gene therapies advance towards finish line. Mullard A Nat Rev Drug Discov; 2011 Sep; 10(10):719-20. PubMed ID: 21959273 [No Abstract] [Full Text] [Related]
15. Glybera and the future of gene therapy in the European Union. Miller N Nat Rev Drug Discov; 2012 May; 11(5):419. PubMed ID: 22679644 [No Abstract] [Full Text] [Related]
16. Gene, stem cell, and future therapies for orphan diseases. Phillips MI Clin Pharmacol Ther; 2012 Aug; 92(2):182-92. PubMed ID: 22739143 [TBL] [Abstract][Full Text] [Related]
17. A patient and family perspective on gene therapy for rare diseases. Kent A; Oosterwijk C J Gene Med; 2007 Oct; 9(10):922-3. PubMed ID: 17880044 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell gene therapy: progress on the clinical front. Cavazzana M Hum Gene Ther; 2014 Mar; 25(3):165-70. PubMed ID: 24579931 [No Abstract] [Full Text] [Related]
19. 'Bespoke Gene Therapy Consortium' sets out to enable gene therapies for ultra-rare diseases. Kingwell K Nat Rev Drug Discov; 2021 Dec; 20(12):886-887. PubMed ID: 34773079 [No Abstract] [Full Text] [Related]
20. Cellular therapies: a Canadian blood services research and development symposium. Shehata N; Lin Y; Pendergrast J; Branch DR Transfus Med Rev; 2007 Oct; 21(4):317-36. PubMed ID: 17900493 [No Abstract] [Full Text] [Related] [Next] [New Search]